Notable Amicus Therapeutics Insider Trades $150K In Company Stock

Bradley Campbell, Chief Operating Officer at Amicus Therapeutics FOLD, made a large buy and sell of company shares on October 1, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Bradley Campbell exercised options to purchase 10,515 Amicus Therapeutics shares at a price of $4.38 per share for a total of $46,056 on October 1. They then sold their shares on the same day in the open market. They sold at a price of $10.00 to raise a total of $105,150 from the stock sale.

Following the transaction, Campbell still owns 457,268 shares of the company, worth $4,604,688.

Amicus Therapeutics shares are trading up 2.55% at $10.07 at the time of this writing on Tuesday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

The Importance of Insider Transactions

Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.

In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

Important Transaction Codes

Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.

Check Out The Full List Of Amicus Therapeutics's Insider Trades.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsInsider TradesTrading IdeasBradley CampbellBZI-ITInsider sells
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...